Lumida
/QDEL
⌘K
QuidelOrtho Corp

QuidelOrtho Corp

QDEL
$11.78USD-3.05%-0.37 today

MARKET CAP

807.8M

P/E (TTM)

FWD P/E

DAY RANGE

$12 – $12

52W RANGE

$10
$36

AI Summary

Stalk
TrimMedium

QDEL remains under pressure, trading below its declining 200-day SMA with medium-term distribution evident under the 20-day EMA and capped by the 50-day SMA. Short-term action is neutral around the converged 9/20-day EMA cluster, offering no clear entry signal. Execution is deferred, looking to trim into rallies toward these moving-average resistance levels.

  • 2.8% stock rise post-ADLM showcase highlights diagnostic innovation
  • New York strategic investment underscores institutional confidence
  • Negative earnings yield indicates severe profit pressure
Full analysis →

Buying

7

institutions

Selling

3

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY11.20 M196.21 M+753.40 K+14.3%0.00%
TR

T. Rowe Price Investment Management, Inc.

Q2 2026

SELL1.74 M30.54 M+-3.89 M-67.0%0.02%
AC

Aqr Capital Management LLC

Q2 2026

BUY911.12 K15.96 M+736.39 K+455.9%0.01%
MM

Millennium Management LLC

Q2 2026

BUY722.48 K12.65 M+440.26 K+172.9%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL126.72 K2.31 M+-10.01 K+10.7%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUY91.20 K1.60 M+41.60 K+96.0%0.00%
JH

Janus Henderson Group Plc

Q1 2026

BUY57.99 K953.00 K+28.99 K+15.1%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUYNEW40.88 K716.01 K+40.88 K+0.0%0.01%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL30.42 K532.84 K+-731.75 K-95.7%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUY819.0014.35 K+511.00+183.5%0.00%